Diagnostic value of serum cancer antigen 125 in ovarian cancer patients
Amongst all gynecological cancers, ovarian cancer is the most lethal malignancy worldwide, aggressive local invasion and the lack of sensitive early screening methods, poses the most difficult in early diagnosis, furthermore, its high mortality rate has made it one of the most investigated fields in gynecological oncology during this year in USA. The aim of the study is to assess the level of serum biomarker cancer antigen (CA-125), among ovarian cancer women at Khartoum State - Sudan.